Trial under way for Alumend's device to treat artery disease

Alumend is conducting an early-stage clinical study in New Zealand to test a device that can be used to help treat patients with peripheral arterial disease. The Sioux Falls, S.D.-based startup aims to refine the technology after the initial trial and advance it to U.S. clinical studies, founding member Ron Utecht said at a biotech conference in Chicago.

View Full Article in:

Argus Leader (Sioux Falls, S.D.) (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN